2-Aminoquinoline compounds

Details for Australian Patent Application No. 2002352878 (hide)

Owner Merck & Co., Inc.

Inventors Jiang, Jinlong; Sailer, Andreas W; Chang, Lehua; Hoang, MyLe; Young, Jonathan R; Devita, Robert J; Lin, Peter; Chaung, Danny

Agent Spruson & Ferguson

Pub. Number AU-B-2002352878

PCT Number PCT/US02/37556

PCT Pub. Number WO2003/045313

Priority 60/333,581 27.11.01 US

Filing date 22 November 2002

Wipo publication date 10 June 2003

Acceptance publication date 22 November 2007

International Classifications

C07D 215/38 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/403 (2006.01) - condensed with carbocyclic rings, e.g. carbazole

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61K 31/47 (2006.01) - Quinolines

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/4995 (2006.01) - Pyrazines or piperazines forming part of bridged ring systems

A61K 31/5377 (2006.01)

A61K 31/54 (2006.01) - having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame

A61K 31/55 (2006.01) - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61P 1/14 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 7/10 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 15/00 Drugs for genital or sexual disorders

Event Publications

20 March 2003 Complete Application Filed

  Priority application(s): 60/333,581 27.11.01 US

21 August 2003 Application Open to Public Inspection

  Published as AU-B-2002352878

22 November 2007 Application Accepted

  Published as AU-B-2002352878

3 April 2008 Standard Patent Sealed

21 January 2010 Amendment Made

  The nature of the amendment is: Amend the patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

14 June 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002352879-METHOD AND APPARATUS FOR UNLOCKING A COMPUTER SYSTEM HARD DRIVE

2002352877-Methods and systems for preparing blood products